John Libbey Eurotext

Magnesium Research

The effects of magnesium supplementation on subjective anxiety Volume 29, numéro 3, September 2016

  • [1] King D.E., Mainous A.G. 3rd., Geesey M.E., Woolson R.F. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005;24:166-171.
  • [2] Ford E.S., Mokdad A.H. Dietary magnesium intake in a national sample of US adults. J Nutr. 2003;133:2879-2882.
  • [3] Dolega-Cieszkowski J.H., Bobyn J.P., Whiting S.J. Dietary intakes of Canadians in the 1990s using population-weighted data derived from the provincial nutrition surveys. Appl Physiol Nutr Metabol. 2006;31:753-758.
  • [4] Song Y., Sesso H.D., Manson J.E., Cook N.R., Buring J.E., Liu S. Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. Am J Cardiol. 2006;98:1616-1621.
  • [5] Pavlinac D., Langer R., Lenhard L., Deftos L. Magnesium in affective-disorders. Biol Psychiatry. 1979;14:657-661.
  • [6] Chouinard G., Beauclair L., Geiser R., Etienne P. A pilot study of magnesium aspartate hydrochloride (Magnesiocard®) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog Neuro-Psychopharmacol Biol Psychiatry. 1990;14:171-180.
  • [7] Cox I.M., Campbell M.J., Dowson D. Red-blood-cell magnesium and chronic fatigue syndrome. Lancet. 1991;337:757-760.
  • [8] Derom M.L., Sayón-Orea C., Martínez-Ortega J.M., Martínez-González M.A. Magnesium and depression: a systematic review. Nutr Neurosci. 2013;16:191-206.
  • [9] Singewald N1, Sinner C., Hetzenauer A., Sartori S.B., Murck H. Magnesium-deficient diet alters depression- and anxiety-related behavior in mice - influence of desipramine and Hypericum perforatum extract. Neuropharmacology. 2004;47:1189-1197.
  • [10] Jacka F.N., Overland S., Stewart R., Tell G.S., Bjelland I., Mykletun A. Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study. Aust NZ J Psychiatry. 2009;43:45-52.
  • [11] Eby G.A., Eby K.L. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67:362-370.
  • [12] Arzoz-Fàbregas M., Ibarz-Servio L., Fernández-Castro J. Chronic stress and calcium oxalate stone disease: influence on blood cortisol and urine composition. Urology. 2013;82:1246-1252.
  • [13] Kessler R.C., Aguilar-Gaxiola S., Alonso J. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18:23-33.
  • [14] Murck H. Magnesium and affective disorders. Nutr Neurosci. 2002;5:375-389.
  • [15] Pyndt Jørgensen B., Winther G., Kihl P. Dietary magnesium deficiency affects gut microbiota and anxiety-like behaviour in C57BL/6N mice. Acta Neuropsychiatr. 2015;27:307-311.
  • [16] Sartori S.B., Whittle N., Hetzenauer A., Singewald N. Magnesium deficiency induces anxiety and HPA axis dysregulation: Modulation by therapeutic drug treatment. Neuropharmacology. 2012;62:304-312.
  • [17] Iezhitsa I.N., Spasov A.A., Kharitonova M.V., Kravchenko M.S. Effect of magnesium chloride on psychomotor activity, emotional status, and acute behavioural responses to clonidine, d-amphetamine, arecoline, nicotine, apomorphine, and L-5-hydroxytryptophan. Nutr Neurosci. 2011;14:10-24.
  • [18] Poleszak E1, Szewczyk B., Kedzierska E., Wlaź P., Pilc A., Nowak G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav. 2004;78:7-12.
  • [19] Hanus M., Lafon J., Mathieu M. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin. 2004;20:63-71.
  • [20] Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:30-35.
  • [21] Bourgeois M. Rôle du Magne-B6 dans les manifestations anxieuses en pratique médicale courante. Psychiatr Pract Med 1987; 39: 18-22.
  • [22] Scharbach H. Anxiété et Magné B6. La Vie Médicale. 1988;17:867.
  • [23] Freeman E.W. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis1. Psychoneuroendocrinology. 2003;28:S25-37.
  • [24] De Souza M.C., Walker A.F., Robinson P.A., Bolland K. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000;9:131-139.
  • [25] Fathizadeh N., Ebrahimi E., Valiani M., Tavakoli N., Yar M.H. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res. 2010;15:S401-S405.
  • [26] Moos R.H. The development of a menstrual distress questionnaire. Psychosom Med. 1968;30:853-867.
  • [27] Quaranta S., Buscaglia M.A., Meroni M.G., Colombo E., Cella S. Pilot study of the efficacy and safety of a modified-release magnesium 250mg tablet (Sincromag) for the treatment of premenstrual syndrome. Clin Drug Invest. 2007;27:51-58. ®
  • [28] Walker A.F., De Souza M.C., Vickers M.F., Abeyasekera S., Collins M.L., Trinca L.A. Magnesium Supplementation Alleviates Premenstrual Symptoms of Fluid Retention. J Womens Health. 1998;7:1157-1165.
  • [29] Walker A.F., De Souza M.C., Marakis G., Robinson P.A., Morris A.P., Bolland K.M. Unexpected benefit of sorbitol placebo in Mg intervention study of premenstrual symptoms: implications for choice of placebo in RCTs. Med Hypotheses. 2002;58:213-220.
  • [30] Rouillon, F., M. Lejoyeux, C. Martineau, A Double-blind Controlled Study of PCR 7060 vs. Buspirone in the Treatment of Generalised Anxiety Disorder Conference Abstract. 8th European College of Neuropsychopharmacology Congress. Venice, Italy. 30th September 4th October, 1995.
  • [31] Sramek J.J., Tansman M., Suri A. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. J Clin Psychiatry. 1996;57:287-291.
  • [32] Taylor D.P. Buspirone, a new approach to the treatment of anxiety. FASEB J. 1988;2:2445-2452.
  • [33] Strand M1, Hetta J., Rosen A. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam. J Clin Psychiatry. 1990;51:S40-S45.
  • [34] Murck H., Steiger A. Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men - possible therapeutic implications. Psychopharmacology. 1998;137:247-252.
  • [35] Held K., Antonijevic I.A., Künzel H. Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry. 2002;35:135-143.
  • [36] Mocci F., Canalis P., Tomasi P.A., Casu F., Pettinato S. The effect of noise on serum and urinary magnesium and catecholamines in humans. Occup Med (Lond). 2001;51:56-61.
  • [37] Takase B., Akima T., Uehata A., Ohsuzu F., Kurita A. Effect of chronic stress and sleep deprivation on both flow-mediated dilation in the brachial artery and the intracellular magnesium level in humans. Clin Cardiol. 2004;27:223-227.